Sequenom Announces Enhanced Sequencing Series for MaterniT21 PLUS Test
October 22, 2013 at 07:09 AM EDT
Sequenom (NASDAQ: SQNM ) announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21™ PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test will begin reporting additional findings for the presence of subchromosomal microdeletions and
